13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q4 2025 · Filed February 10, 2026 · Accession 0001104659-26-012485
Total Value
$310.5M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 7,903,838 | $286.8M | 92.37% |
| 2 | Phathom Pharmaceuticals, Inc. | PHAT | 1,429,014 | $23.7M | 7.63% |